Pinnacle Associates’s Kite Pharma, Inc. KITE Stock Holding History

Pinnacle Associates’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-234,730	Closed	-$42.2M	–	705
2017 Q3	$42.2M	Sell	234,730 -7,172	-3%	-$999K	0.78%	34
2017 Q2	$25.1M	Sell	241,902 -13,931	-5%	-$1.14M	0.48%	61
2017 Q1	$20.1M	Buy	255,833 +97,843	+62%	+$6.05M	0.38%	73
2016 Q4	$7.08M	Buy	+157,990	New	+$7.75M	0.14%	161

Pinnacle Associates's KITE Position: Q4 2017 in Review

Pinnacle Associates sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 234,730 shares — an estimated $42.2M sold.

Pinnacle Associates first reported a position in KITE in Q4 2016 and held it in 4 quarters. The position peaked at $42.2M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Pinnacle Associates reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Pinnacle Associates sold 234,730 Kite Pharma, Inc. shares in Q4 2017, an estimated $42.2M.
Pinnacle Associates first reported a position in Kite Pharma, Inc. in Q4 2016 and held it in 4 quarters.
Pinnacle Associates's Kite Pharma, Inc. position peaked at $42.2M in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Pinnacle Associates's 13F filing for Q4 2017, filed 12 Feb 2018.